← Back to Screener
Smith & Nephew plc (SNN)
Price$34.21
Favorite Metrics
Price vs S&P 500 (26W)-12.45%
Price vs S&P 500 (4W)-4.33%
Market Capitalization$10.82B
P/E Ratio (Annual)23.39x
Indicated Dividend Yield (Annual)2.29%
All Metrics
P/CF (Annual)11.38x
Book Value / Share (Quarterly)$6.22
P/TBV (Annual)3.21x
Indicated Dividend (Annual)$27.92
Revenue Growth (3Y)5.73%
Cash Flow / Share (Quarterly)$1.00
Payout Ratio (TTM)52.80%
Price vs S&P 500 (YTD)-1.30%
Gross Margin (TTM)68.01%
Net Profit Margin (TTM)10.14%
EPS (TTM)$0.72
10-Day Avg Trading Volume1.80M
EPS Excl Extra (TTM)$0.72
Revenue Growth (5Y)6.21%
EPS (Annual)$0.72
Dividend / Share (Annual)$0.38
ROI (Annual)7.25%
Gross Margin (Annual)68.25%
Net Profit Margin (5Y Avg)7.26%
Cash / Share (Quarterly)$0.66
P/E Basic Excl Extra (TTM)23.39x
Revenue Growth QoQ (YoY)7.38%
EPS Growth (5Y)6.98%
P/E Normalized (Annual)23.39x
ROA (Last FY)5.98%
Revenue Growth TTM (YoY)6.09%
EBITD / Share (TTM)$1.09
ROE (5Y Avg)7.67%
Operating Margin (TTM)12.88%
Cash Flow / Share (Annual)$1.00
P/B Ratio2.76x
P/B Ratio (Quarterly)2.68x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)2.82x
Net Interest Coverage (TTM)4.80x
ROA (TTM)5.91%
EPS Growth QoQ (YoY)70.05%
EV / EBITDA (TTM)18.26x
EPS Incl Extra (Annual)$0.72
Current Ratio (Annual)2.57x
Quick Ratio (Quarterly)1.25x
3-Month Avg Trading Volume1.80M
52-Week Price Return28.36%
EV / Free Cash Flow (Annual)20.41x
P/E Incl Extra (TTM)23.39x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$5.19
P/S Ratio (Annual)2.37x
Asset Turnover (Annual)0.59x
52-Week High$1441.50
Operating Margin (5Y Avg)10.58%
EPS Excl Extra (Annual)$0.72
CapEx CAGR (5Y)-0.46%
Tangible BV CAGR (5Y)3.05%
26-Week Price Return-3.70%
Quick Ratio (Annual)1.18x
13-Week Price Return2.14%
Total Debt / Equity (Annual)0.63x
Current Ratio (Quarterly)2.57x
Enterprise Value$17,387.501
Revenue / Share Growth (5Y)6.31%
Asset Turnover (TTM)0.58x
Book Value / Share Growth (5Y)0.64%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)0.87x
Pretax Margin (Annual)12.64%
Cash / Share (Annual)$0.66
3-Month Return Std Dev23.52%
Gross Margin (5Y Avg)70.14%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)14.51%
EBITDA Interim CAGR (5Y)0.13%
ROE (Last FY)11.82%
Net Interest Coverage (Annual)5.93x
EPS Basic Excl Extra (Annual)$0.72
P/FCF (TTM)17.16x
Receivables Turnover (TTM)4.41x
EV / Free Cash Flow (TTM)20.41x
Total Debt / Equity (Quarterly)0.63x
EPS Incl Extra (TTM)$0.72
Receivables Turnover (Annual)5.57x
ROI (TTM)7.10%
Dividend Growth Rate (5Y)0.41%
P/S Ratio (TTM)2.37x
Pretax Margin (5Y Avg)8.44%
Revenue / Share (Annual)$7.06
Tangible BV / Share (Annual)$5.19
Forward P/E15.26x
Free OCF CAGR (5Y)11.61%
Price vs S&P 500 (52W)-6.74%
P/E Ratio (TTM)23.39x
EPS Growth TTM (YoY)52.27%
Year-to-Date Return1.94%
5-Day Price Return-0.04%
EPS Normalized (Annual)$0.72
ROA (5Y Avg)3.93%
Net Profit Margin (Annual)10.14%
Month-to-Date Return6.54%
Cash Flow / Share (TTM)$0.75
EBITD / Share (Annual)$1.17
EPS Growth (3Y)41.07%
Operating Margin (Annual)12.88%
LT Debt / Equity (Annual)0.57x
P/CF (TTM)11.38x
ROI (5Y Avg)4.77%
P/E Excl Extra (TTM)23.39x
LT Debt / Equity (Quarterly)0.57x
EPS Basic Excl Extra (TTM)$0.72
P/TBV (Quarterly)3.21x
Payout Ratio (Annual)52.80%
P/B Ratio (Annual)2.68x
Dividend / Share (TTM)$0.38
Inventory Turnover (TTM)0.88x
Pretax Margin (TTM)12.64%
Book Value / Share (Annual)$6.22
Price vs S&P 500 (13W)-0.72%
Net Margin Growth (5Y)0.64%
Dividend Yield (TTM)2.26%
Beta0.98x
P/FCF (Annual)17.16x
Revenue / Share (TTM)$7.12
ROE (TTM)11.55%
52-Week Low$960.80
Industry Peers — Orthopedic & Prosthetic Devices(25)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
SNNSmith & Nephew plc | 2.37x | 6.21% | 68.01% | 12.88% | $34.21 |
ISRGIntuitive Surgical Inc. | 16.54x | 18.22% | 66.00% | 29.27% | $465.60 |
EWEdwards Lifesciences Corp | 7.77x | 6.70% | 78.01% | 18.41% | $81.44 |
STESTERIS plc | 3.81x | 12.49% | 44.11% | 17.03% | $226.41 |
ZBHZimmer Biomet Holdings, Inc. | 2.31x | 3.22% | 69.71% | 13.34% | $95.48 |
ALGNAlign Technology Inc | 3.41x | 10.30% | 68.27% | 13.53% | $191.66 |
MSAMine Safety Incorporated | 3.60x | 6.82% | 46.46% | 19.83% | $173.50 |
ESTAEstablishment Labs Holdings Inc. | 9.30x | 20.04% | 69.32% | -18.48% | $66.93 |
ENOVEnovis Corporation | 0.68x | -6.05% | 58.16% | -50.09% | $26.27 |
CDRECadre Holdings, Inc. | 2.19x | 8.57% | 42.54% | 11.04% | $30.51 |
AVNSAvanos Medical, Inc. | 1.64x | -0.38% | 50.47% | -8.78% | $24.64 |
About
Smith & Nephew is a UK-based medical device company with three core segments: orthopedic devices (41% of revenue), sports medicine and arthroscopic technologies (30%), and advanced wound care (29%). The company generates over half its revenue from North America, with the remainder split between developed and emerging markets.